Tobevibart
- Generic Name
- Tobevibart
A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV Infection
- First Posted Date
- 2025-03-30
- Last Posted Date
- 2025-05-20
- Lead Sponsor
- Vir Biotechnology, Inc.
- Target Recruit Count
- 120
- Registration Number
- NCT06903338
- Locations
- 🇲🇩
Investigative Site, Chisinau, Moldova, Republic of
Vaccinal Effect of HBsAg Monoclonal Ab VIR-3434 in Chronic Hepatitis B Infection [VISION]
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2024-11-06
- Lead Sponsor
- University Health Network, Toronto
- Target Recruit Count
- 15
- Registration Number
- NCT06216470
- Locations
- 🇨🇦
University Health Network, Toronto, Ontario, Canada
Dose-Escalation Prime/Boost Therapeutic Vaccination Study Of 2 Chimp Adenoviral Vectors in Adults With Chronic HBV On Nucleos(t)Ide Therapy
- Conditions
- Chronic Hepatitis B
- Interventions
- First Posted Date
- 2023-10-06
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- Virion Therapeutics
- Target Recruit Count
- 48
- Registration Number
- NCT06070051
- Locations
- 🇳🇿
Aotearoa Clinical Trials, Middlemore Hospital, Auckland, New Zealand
🇭🇰Chinese University of Hong Kong, Hong Kong, Hong Kong
🇳🇿Auckland City Hospital, Auckland, New Zealand
A Platform Study to Evaluate Investigational Therapies in Chronic Hepatitis B Infection
- Conditions
- Hepatitis B, Chronic
- Interventions
- First Posted Date
- 2022-11-10
- Last Posted Date
- 2025-04-06
- Lead Sponsor
- Vir Biotechnology, Inc.
- Target Recruit Count
- 150
- Registration Number
- NCT05612581
- Locations
- 🇬🇧
Investigative Site, Manchester, United Kingdom
Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and VIR-3434
- First Posted Date
- 2022-08-02
- Last Posted Date
- 2024-05-03
- Lead Sponsor
- Vir Biotechnology, Inc.
- Target Recruit Count
- 144
- Registration Number
- NCT05484206
- Locations
- 🇺🇸
Inland Empire Clinical Trials, Rialto, California, United States
🇺🇸Orange County Research Center, Tustin, California, United States
🇺🇸Floridian Clinical Research, Miami Lakes, Florida, United States
SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.
- First Posted Date
- 2022-07-18
- Last Posted Date
- 2024-08-09
- Lead Sponsor
- Vir Biotechnology, Inc.
- Target Recruit Count
- 124
- Registration Number
- NCT05461170
- Locations
- 🇬🇧
Investigative Site, Manchester, United Kingdom
Study of VIR-2218, VIR-3434, And/or PEG-IFNα in Subjects with Chronic Hepatitis B Virus Infection
- Conditions
- Hepatitis B, Chronic
- Interventions
- First Posted Date
- 2021-04-22
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- Vir Biotechnology, Inc.
- Target Recruit Count
- 244
- Registration Number
- NCT04856085
- Locations
- 🇬🇧
Investigative Site, Manchester, United Kingdom
Study of VIR-3434 in Healthy Volunteers and Patients With Chronic Hepatitis B Virus Infection
- First Posted Date
- 2020-06-09
- Last Posted Date
- 2024-10-08
- Lead Sponsor
- Vir Biotechnology, Inc.
- Target Recruit Count
- 113
- Registration Number
- NCT04423393
- Locations
- 🇬🇧
Investigative Site, Manchester, United Kingdom
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.